Heart Failure and Aortic Stenosis - What TAVI Can Offer
Published: 12 August 2022
-
Views:
2067 -
Likes:
7
-
Views:
2067 -
Likes:
7
-
2m 4sPart 1 Welcome and Introduction Ralph Stephan von Bardeleben, Jose Luis Zamorano, Victoria Delgado, Davide Capodanno, Sasha Koul
-
2m 54sPart 2 Valve Clinic Patient Presentation Victoria Delgado
-
7m 38sPart 3 How To Avoid Common Pitfalls in the Diagnosis With Echo? Victoria Delgado, Jose Luis Zamorano
-
15m 31sPart 4 What Is Your Experience With TAVI, and Which Long Term Outcomes Can We Expect? Davide Capodanno, Ralph Stephan von Bardeleben, Victoria Delgado
-
1m 16sPart 5 What Would Be the Ideal Treatment for This Patient? A Panel Discussion. Jose Luis Zamorano, Ralph Stephan von Bardeleben, Davide Capodanno, Victoria Delgado, Sasha Koul
-
9m 3sPart 6 How Was This Patient Treated and Why? Victoria Delgado
Overview
In this video series, first presented at the ESC Congress 2022, held in Barcelona, Prof Ralph Stephan von Bardeleben, Prof Jose Luis Zamorano, Dr Victoria Delgado, Prof Davide Capodanno and Dr Sasha Koul discuss the diagnosis of low flow/low gradient aortic stenosis, which patients gain the most benefit from TAVI and how to avoid heart failure in aortic stenosis patients. Join this international faculty discussion to discover the latest TAVI durability data.
We'd like to hear your Feedback
Learning Objectives:
- Lean how to diagnose low flow/low gradient aortic stenosis
- Identify which patients will benefit most from TAVI
- Discover how to avoid heart failure in aortic stenosis patients and discuss the latest TAVI durability data
Target Audience
- General Cardiologists
- Interventional Cardiologists
More from this programme
Part 1
Welcome and Introduction
1 session | |
Welcome and Introduction | Watch now |
Part 2
Valve Clinic Patient Presentation
1 session | |
Valve Clinic Patient Presentation | Watch now |
Part 3
How To Avoid Common Pitfalls in the Diagnosis With Echo?
Part 4
What Is Your Experience With TAVI, and Which Long Term Outcomes Can We Expect?
Part 5
What Would Be the Ideal Treatment for This Patient? A Panel Discussion.
Part 6
How Was This Patient Treated and Why?
Part 7
Final Remarks & Take Home Messages
1 session | |
Final Remarks & Take Home Messages | Watch now |
Faculty Biographies
Jose Luis Zamorano
Professor of Medicine and Chief of Cardiology
Jose L Zamorano is Professor of Medicine at the University Alcala de Henares, Madrid, and the Chief of Cardiology at the University Hospital Ramón y Cajal.
Prof Zamorano’s has a broad range of research interests including heart failure, ischaemic heart disease, cardiovascular risk factors and cardiovascular imaging modalities. Within these fields, Prof Zamorano he is widely published with over 500 articles and twenty books including the European Textbook of Cardiovascular Imaging.
Ralph von Bardeleben
Head of the Centre of Structural Heart Disease Interventions and the Heart Valve Centre
Prof Ralph Stephan von Bardeleben is the Head of the Center of Structural Heart Disease Interventions and the Heart Valve Center in Mainz, Germany
Prof Bardeleben is Past-President of the German working group on Echocardiography of the German Society of Cardiology and a member of several medical societies. He serves on the Clinical Program commission and at your region program of the ESC and is a reviewer for several peer-reviewed journals. Newly elected co-editor-in-chief of Echocardiography Journal.
He participates as PI, steering committee member and core laboratory in several medical device trials, including a German Federal Institute for Drugs and Medical Devices (BfArM)-approved first- or early-in-human medical device implant trials.